Pain Management Technologies, Inc. v. Protocol Solutions, LLC et al.

CourtDistrict Court, N.D. Ohio
DecidedApril 27, 2026
Docket1:25-cv-00796
StatusUnknown

This text of Pain Management Technologies, Inc. v. Protocol Solutions, LLC et al. (Pain Management Technologies, Inc. v. Protocol Solutions, LLC et al.) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Pain Management Technologies, Inc. v. Protocol Solutions, LLC et al., (N.D. Ohio 2026).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF OHIO

Pain Management Technologies, Inc. Case No. 1:25-cv-00796

Plaintiff,

-vs- JUDGE PAMELA A. BARKER

Protocol Solutions, LLC et al.,

Defendants. MEMORANDUM OPINION & ORDER

Currently pending before the Court is Plaintiff Pain Management Technologies, Inc.’s (“Plaintiff”) Motion for Leave to File Second Amended Complaint (“SAC”) (the “Motion”). (Doc. No. 18.)1 Defendants Protocol Solutions LLC, Branson Healing Arts, and Nerve Reviver (collectively “Defendants”) filed their Opposition on September 19, 2025, and Plaintiff filed its Reply on September 26, 2025. (Doc. Nos. 19, 20.) For the following reasons, the Motion is DENIED. I. Procedural History On April 21, 2025, Plaintiff filed its Complaint asserting the following claims against Defendants (1) copyright infringement under 17 U.S.C. § 501 et. seq. (Claim 1); (2) common law trademark infringement (Claim 2); and (3) unfair competition under federal and Ohio law (Claim 3). (Doc. No. 1.) On July 18, 2025, Defendants filed their Motion to Dismiss Pursuant

1 Throughout its pleadings, Plaintiff refers to itself as “NerveSpa.” See, e.g., (Doc. No. 57 at ¶¶ 27, 30-32, 36-37, 57-59, 72-74, 77); (Doc. No. 18-2 at ¶¶ 27, 30-32, 36-37, 59-61, 76-77, 80.) to Federal Rule of Civil Procedure 12(b)(6) asserting that the Complaint failed to state a claim. (Doc. No. 12.) On August 18, 2025, Plaintiff filed a First Amended Complaint (“FAC”). (Doc. No. 15.) Therein, Plaintiff added additional facts but also alleged three new claims: (1) trade dress infringement under the Lanham Act, 15 U.S.C. § 1125(a) (Claim 4); (2) false designation of origin and unfair competition in violation of 15 U.S.C. § 1125(a) (Claim 5); and (3) deceptive

trade practices under R.C. 4165.02 (Claim 6). (Doc. No. 15.) Additionally, Plaintiff represents that “[t]his [FAC] is being filed in response to the Defendants’ motion to dismiss filed on July 18, 2025.” See (id. at PageID # 114 n. 1.) The following day, this Court issued a non-document Order. Therein, the Court found that “Plaintiff’s deadline to file its Amended Complaint as a matter of course elapsed twenty- one (21) days after Defendants filed their Motion to Dismiss,” and ordered Plaintiff “to file a Motion for Leave to File an Amended Complaint Instanter by 8/22/25.” See Non-Doc. dated Aug. 19, 2025. Then, on August 20, 2025, Plaintiff filed its Motion for Leave to Have Amended Complaint Deemed Filed Instanter. (Doc. No. 16 at PageID # 160.) The following day, this

Court granted that motion and designated the FAC as the operative complaint in the action. See Non-Doc. dated Aug. 21, 2025. In a subsequent order, the Court then denied Defendant’s Motion to Dismiss as moot. See id. On August 29, 2025, Defendants filed their Unopposed Motion for Extension of Time to file their answer or respond to the FAC. (Doc. No. 17.) Therein, Defendants indicated that while they were required to file their responsive pleading by September 2, 2025, they recently learned

2 that Plaintiff intended to seek leave to file a SAC. (Id.) Defendants represent that the parties were “unable to reach agreement on that amendment” and explained that “because Plaintiff’s proposed [SAC], like its FAC, asserts nearly identical causes of action to Plaintiff’s original complaint, Defendants anticipate they will have to oppose its entry based on pleading deficiencies.” (Id.) Defendants argued that under these circumstances it would be “far more efficient” to suspend their answer date to the FAC until after Plaintiff’s anticipated motion for

leave to file a SAC was filed, briefed and decided by this Court. (Id.) The Court agreed with Defendants, stayed Defendants’ deadline to answer or otherwise respond to the FAC, and ordered that if Plaintiff intended to file a motion for leave to file a SAC, it should do so by September 8, 2025. See Non-Doc. dated Aug. 29, 2025. On September 5, 2025, Plaintiff filed the instant Motion. (Doc. No. 18.) On September 19, 2025, Defendants filed their Opposition to which Plaintiff replied on September 26, 2025. (Doc. Nos. 19, 20.) Accordingly, the Motion is ripe for review. II. Background A. Factual Allegations in the FAC2 The FAC sets forth the following allegations. Plaintiff’s relationship with Defendants

“started years ago when the Defendants were a customer of Plaintiff.” (Id. at ¶ 17.) Plaintiff “designs, manufactures, and sells innovative therapeutic devices for nerve-centered care.” (Doc. No. 15 at ¶ 23.) “Defendants bought products from the Plaintiff and even had the Plaintiff do a private label line for the Defendants for a period of time.” (Id. at ¶ 18.) Through this relationship,

2 The FAC is the operative complaint in the action. See Non-Doc. dated Aug. 21, 2025.

3 Defendants “learned the Plaintiff’s know-how and trade secrets and were in receipt of the Plaintiff’s marketing materials.” (Id. at ¶ 19.) As time went on, Defendants “began to strategically copy the Plaintiff’s product line and business model.” (Id. at ¶ 20.) Defendants’ product line is called Nerve Reviver.3 (Id. at ¶ 39.) Defendants then began “reaching out to the Plaintiff’s overseas manufacturer and requested that the product be made for them.” (Id. at ¶ 21.) “Defendants then used the Plaintiff’s goodwill in

their marketing efforts by comparing their ‘technology’ to the Plaintiff’s.” (Id. at ¶ 22.) 1. Defendants’ Copyright and Trademark Infringements and Other Deceptive Trade Practices

“Plaintiff also owns valid copyrights in certain original works,” which “are original and fixed in a tangible medium, and they contain creative expression beyond mere factual listings.” (Id. at ¶¶ 28-29.) “Defendants, without authorization, have copied, reproduced, displayed, and distributed NerveSpa’s copyrighted works in connection with the sale of competing products.” (Id. at ¶ 30); see also (id. at ¶ 49.) “[C]ertain acts of infringement occurred after the effective date of NerveSpa’s copyright registrations.” (Id. at ¶ 31.) “Defendants are not authorized in any way to sell their infringing products or to use the copyrighted materials owned by the Plaintiff.” (Id. at ¶ 49.) a. NerveSpa Product Image In their marketing efforts, Defendants misused an image of Plaintiff’s product as seen below:

3 Nerve Reviver is a named Defendant in the action. However, Defendants argue in their Opposition that Nerve Reviver is “a non-existent entity.” (Doc. No. 19 at PageID # 250.)

4 It's called

(Id. at § 39.) Plaintiff does not allege that it owns the copyright to the image shown above. b. NerveSpa Research Summary Plaintiff alleges that its “entire nerve spa research summary 1s copyrighted.” (/d. at § 41.) This “‘Research Summary’ document” “is used to market and explain the therapeutic benefits of its products.” (/d. at § 28.) Attached as Exhibit 1 to the FAC is the certificate of registration for United States Copyright Number TX 9-472-854 entitled “[nJerve spa research summary” (the “°854 copyright”). (Doc. No. 15-1.) The ‘854 copyright has an effective date of registration of February 3, 2025 and a registration decision date of February 27, 2025. (/d.) Defendants copied “Plaintiff's nerve spa research summary and included it in their product disclosures marketed with their product.”* (Doc. No. 15 at § 40.) “Defendant’s marketing materials, verbatim, are copies of the Plaintiff's copyrighted materials.” (Doc. No. 15 at ¥ 44.) c.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Pain Management Technologies, Inc. v. Protocol Solutions, LLC et al., Counsel Stack Legal Research, https://law.counselstack.com/opinion/pain-management-technologies-inc-v-protocol-solutions-llc-et-al-ohnd-2026.